comparemela.com

Latest Breaking News On - Drug approval license - Page 1 : comparemela.com

Basilea announces approval for additional formulation of antifungal Cresemba® (isavuconazole) in China

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesBasel stadtBasel allschwilNils schrDavid veitchHead of corporate communications investor relationsBasilea pharmaceutica ltdSwiss exchangeBasilea pharmaceutica international ltdPfizer incChinese national medical products administrationEuropean unionNational medical products administrationDrug approval licenseLatin americaMiddle east

Basilea Pharmaceutica AG: Basilea announces approval for additional formulation of antifungal Cresemba (isavuconazole) in China

Chinese National Medical Products Administration (NMPA) granted Drug Approval License to Basilea's license partner, Pfizer Inc.Intravenous use of Cresemba approved for the treatment of adult patients with

United statesBasel stadtBasel allschwilNils schrDavid veitchHead of corporate communications investor relationsSwiss exchangeBasilea pharmaceutica ltdBasilea pharmaceutica international ltdPfizer incChinese national medical products administrationEuropean unionNational medical products administrationDrug approval licenseLatin americaMiddle east

Investegate |Basilea Pharmaceutica AG Announcements | Basilea Pharmaceutica AG: Basilea announces approval for additional formulation of antifungal Cresemba® (isavuconazole) in China

Investegate announcements from Basilea Pharmaceutica AG, Basilea announces approval for additional formulation of antifungal Cresemba® (isavuconazole) in China

United statesBasel stadtBasel allschwilNils schrDavid veitchHead of corporate communications investor relationsBasilea pharmaceutica ltdSwiss exchangeBasilea pharmaceutica international ltdPfizer incChinese national medical products administrationEuropean unionNational medical products administrationDrug approval licenseLatin americaMiddle east

Basilea Partner Pfizer Gets Approval In China For Addl Formulation Of Antifungal Cresemba In China

(RTTNews) - Basilea Pharmaceutica Ltd. said that its license partner, Pfizer Inc. (PFE), has received a Drug Approval License from the National Me.

United statesPfizer incNational medical products administrationBasilea pharmaceutica ltdDrug approval license

Pfizer (PFE) Approved for Additional Formulation of Cresemba in China

Pfizer (PFE) Approved for Additional Formulation of Cresemba in China
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDavid veitchPfizer incNational medical products administrationBasilea pharmaceutica ltdWall streetPharmaceutica ltdDrug approval license

vimarsana © 2020. All Rights Reserved.